Abstract
Although urolithiasis is a common disease in the European population, bilateral staghorn stones are a relatively rare variant of nephrolithiasis. It is often associated with a chronic urinary tract infection or a metabolic disorder. The aim of this paper is to show an example of the treatment of bilateral staghorn stones in a patient chronically infected with a resistant strain of Proteus mirabilis. Percutaneous nephrolithotripsy (PCNL) is currently the gold standard of treatment. And this is the way the patient was managed. In the following section, the authors sought to describe new reports on this treatment method and how it could be improved. Conservative treatment does not appear to be a safe alternative. And of the other surgical treatments, PCNL has the greatest benefits. Nearly 68% of patients with bilateral staghorn stones have some underlying metabolic disorder in a small sample of patients. It seems reasonable, therefore, to introduce genetic and metabolic diagnosis in younger patients with the aim of prevention through diet or pharmacotherapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
